Appili Therapeutics Announces Mailing of the Management Information Circular in Connection with the Special Meeting of Shareholders [Financial Post (Toronto, Ontario, Canada)]
Aditxt, Inc. (ADTX)
Company Research
Source: Financial Post
Your vote is important no matter how many votes you hold. Shareholders who have questions or need assistance with voting their shares should contact info@appilitherapeutics.com HALIFAX, Nova Scotia, Oct. 10, 2024 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “ Company ” or “ Appili ”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, announces its special meeting of shareholder date. The notice of the special meeting of shareholders (the “ Meeting “) and management information circular (the “ Circular” ) will be available on the Company's website at: appilitherapeutics.com/proxy-info/ as well as under Appili's profile on SEDAR+ www.sedarplus.ca Appili's board of directors recommend that shareholders vote in favour of the resolution pursuant to which Aditxt Inc. (“Aditxt”), through its wholly-owned subsidiary, Adivir, Inc., agreed to acquire all of the issued and outstanding Class A common
Show less
Read more
Impact Snapshot
Event Time:
ADTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADTX alerts
High impacting Aditxt, Inc. news events
Weekly update
A roundup of the hottest topics
ADTX
News
- Appili Therapeutics Announces Receipt of Final Court Order for Arrangement with Aditxt, Inc. [Yahoo! Finance]Yahoo! Finance
- Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 [Yahoo! Finance]Yahoo! Finance
- Evofem Biosciences Announces Financial Results for the Third Quarter of 2024PR Newswire
- Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025 [Canadian Business Journal (Canada)]Canadian Business Journal
- Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025 [Yahoo! Finance]Yahoo! Finance
ADTX
Sec Filings
- 11/21/24 - Form 8-K/A
- 11/21/24 - Form 8-K/A
- 11/19/24 - Form 8-K
- ADTX's page on the SEC website